spacer
spacer

PDBsum entry 6hep

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Signaling protein PDB id
6hep

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
230 a.a.
15 a.a.
Ligands
ETE ×2
Waters ×735
PDB id:
6hep
Name: Signaling protein
Title: Crystal structure of human 14-3-3 beta in complex with cftr r-domain peptide ps753-ps768
Structure: 14-3-3 protein beta/alpha. Chain: a, b, c, d. Synonym: protein 1054,protein kinasE C inhibitor protein 1,kcip-1. Engineered: yes. Cystic fibrosis transmembrane conductance regulator. Chain: e, f. Synonym: cftr,atp-binding cassette sub-family c member 7,channel conductance-controlling atpase,camp-dependent chloride channel. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: ywhab. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Synthetic: yes. Organism_taxid: 9606
Resolution:
1.86Å     R-factor:   0.204     R-free:   0.251
Authors: L.M.Stevers,C.Ottmann,L.Brunsveld
Key ref: L.M.Stevers et al. (2018). A Thermodynamic Model for Multivalency in 14-3-3 Protein-Protein Interactions. J Am Chem Soc, 140, 14498-14510. PubMed id: 30296824 DOI: 10.1021/jacs.8b09618
Date:
20-Aug-18     Release date:   24-Oct-18    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P31946  (1433B_HUMAN) -  14-3-3 protein beta/alpha from Homo sapiens
Seq:
Struc:
246 a.a.
230 a.a.
Protein chains
Pfam   ArchSchema ?
P13569  (CFTR_HUMAN) -  Cystic fibrosis transmembrane conductance regulator from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1480 a.a.
15 a.a.*
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 4 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: Chains E, F: E.C.5.6.1.6  - channel-conductance-controlling ATPase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: ATP + H2O + closed Cl- channel = ADP + phosphate + open Cl- channel
ATP
+ H2O
+ closed Cl(-) channel
= ADP
+ phosphate
+ open Cl(-) channel
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1021/jacs.8b09618 J Am Chem Soc 140:14498-14510 (2018)
PubMed id: 30296824  
 
 
A Thermodynamic Model for Multivalency in 14-3-3 Protein-Protein Interactions.
L.M.Stevers, P.J.de Vink, C.Ottmann, J.Huskens, L.Brunsveld.
 
  ABSTRACT  
 
Protein-protein interactions (PPIs) are at the core of molecular control over cellular function. Multivalency in PPI formation, such as via proteins with multiple binding sites and different valencies, requires fundamental understanding to address correlated challenges in pathologies and drug development. Thermodynamic binding models are needed to provide frameworks for describing multivalent PPIs. We established a model based on ditopic host-guest systems featuring the effective molarity, a hallmark property of multivalency, as a prime parameter governing the intramolecular binding in divalent interactions. By way of illustration, we study the interaction of the bivalent 14-3-3 protein scaffold with both the nonavalent CFTR and the hexavalent LRRK2 proteins, determining the underlying thermodynamics and providing insights into the role of individual sites in the context of the multivalent platform. Fitting of binding data reveals enthalpy-entropy correlation in both systems. Simulations of speciations for the entire phosphorylated protein domains reveal that the CFTR protein preferably binds to 14-3-3 by combinations including the strongest binding site pS768, but that other binding sites take over when this site is eliminated, leading to only a minor decrease in total affinity for 14-3-3. For LRRK2, two binding sites dominate the complex formation with 14-3-3, but the distantly located pS1444 site also plays a role in complex formation. Thermodynamic modeling of these multivalent PPIs allowed analyzing and predicting the effects of individual sites regarding their modulation via, for example, (de)phosphorylation or small-molecule targeting. The results specifically bring forward the potential of PPI stabilization, as an entry for drug discovery for multivalent PPIs.
 

 

spacer

spacer